NATURAL HEALTH TRENDS CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $39.8M | $43.0M | $43.9M | $49.1M | $60.0M |
| Cost of revenue | $10.5M | $11.2M | $11.2M | $12.7M | $15.0M |
| Gross profit | $29.3M | $31.8M | $32.7M | $36.5M | $45.0M |
| Selling, general & administrative | $14.8M | $15.5M | $16.0M | $16.0M | $17.8M |
| Operating expenses | $31.1M | $33.1M | $34.4M | $36.7M | $43.4M |
| Operating income | -$1.8M | -$1.3M | -$1.7M | -$270,000 | $1.6M |
| Pretax income | -$567,000 | $620,000 | $745,000 | $602,000 | $1.5M |
| Income tax expense | $315,000 | $48,000 | $177,000 | $289,000 | $425,000 |
| Net income | -$882,000 | $572,000 | $568,000 | $313,000 | $1.1M |
| Balance Sheet | |||||
| Cash and equivalents | $6.8M | $13.5M | $56.2M | $69.7M | $83.8M |
| Current assets | $34.2M | $51.0M | $64.2M | $77.6M | $93.5M |
| Total assets | $38.4M | $55.4M | $69.1M | $82.8M | $98.4M |
| Current liabilities | $13.7M | $20.8M | $20.0M | $20.4M | $24.7M |
| Total liabilities | $15.0M | $22.5M | $27.5M | $32.7M | $38.9M |
| Stockholders' equity | $23.4M | $32.9M | $41.6M | $50.2M | $59.5M |
| Cash Flow Statement | |||||
| Cash from operations | -$6.0M | -$3.4M | -$4.3M | -$4.9M | $1.0M |
| Depreciation and amortization | $109,000 | $131,000 | $164,000 | $204,000 | $299,000 |
| Stock-based compensation | $132,000 | $145,000 | $161,000 | $0 | — |
| Capital expenditure | $68,000 | $57,000 | $46,000 | $143,000 | $225,000 |
| Free cash flow | -$6.1M | -$3.4M | -$4.3M | -$5.0M | $791,000 |
| Dividends paid | $9.2M | $9.2M | $9.2M | $9.1M | $9.1M |
Shares outstanding 8.6M · Free float 43.5%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.